Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, ...

Posters will review product characterization and manufacturing data on T-knife’s lead program, TK-6302, a supercharged PRAME ...

Study sets stage for development of synthetic biosensors with custom-built sensing and responses for basic and translational cell engineering applications.

Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under ...

MDX2004 is designed to activate T cells through three unique signalling pathways to enhance immune activation.

The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the ...

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin ...

Drugs to treat inflammatory and autoimmune diseases - such as asthma, psoriasis, rheumatoid arthritis or Chrousos syndrome - ...

The endocannabinoid system is one of the most diffuse neurotransmitter systems in the body and the brain. Understanding its ...

INB-619 demonstrated equivalent efficacy to the FDA approved, commercial T Cell Engagers (TCE) compounds, blinatumomab and mosunetuzumab, with ...